Literature DB >> 21878097

Upper limb artery segmental occlusions due to chronic use of ergotamine combined with itraconazole, treated by thrombolysis.

Edoardo Cervi1, Stefano Bonardelli, Giuseppe Battaglia, Federico Gheza, Roberto Maffeis, Franco Nodari, Roberto Maroldi, Stefano M Giulini.   

Abstract

BACKGROUND: The ergotamine tartrate associated with certain categories of drugs can lead to critical ischemia of the extremities. Discontinuation of taking ergotamine is usually sufficient for the total regression of ischemia, but in some cases it could be necessary thrombolytic and anticoagulant therapy to avoid amputation. CASE REPORT: A woman of 62 years presented with a severe pain left forearm appeared 10 days ago, with a worsening trend. The same symptoms appeared after 5 days also in the right forearm. Physical examination showed the right arm slightly hypothermic, with radial reduced pulse in presence of reduced sensitivity. The left arm was frankly hypothermic, pulse less on radial and with an ulnar humeral reduced pulse, associated to a decreased sensitivity and motility.Clinical history shows a chronic headache for which the patient took a daily basis for years Cafergot suppository (equivalent to 3.2 mg of ergotamine).From about ten days had begun therapy with itraconazole for vaginal candidiasis. The Color-Doppler ultrasound shown arterial thrombosis of the upper limbs (humeral and radial bilateral), with minimal residual flow to the right and no signal on the humeral and radial left artery.
RESULTS: Angiography revealed progressive reduction in size of the axillary artery and right humeral artery stenosis with right segmental occlusions and multiple hypertrophic collateral circulations at the elbow joint. At the level of the right forearm was recognizable only the radial artery, decreased in size. Does not recognize the ulnar, interosseous artery was thin. To the left showed progressive reduction in size of the distal subclavian and humeral artery, determined by multiple segmental steno-occlusion with collateral vessels serving only a thin hypotrophic interosseous artery.Arteriographic findings were compatible with systemic drug-induced disease. The immediate implementation of thrombolysis, continued for 26 hours, with heparin in continuous intravenous infusion and subsequent anticoagulant therapy allowed the gradual disappearance of the symptoms with the reappearance of peripheral pulses.
CONCLUSION: Angiography showed regression of vasospasm and the resumption of flow in distal vessels. The patient had regained sensitivity and motility in the upper limbs and bilaterally radial and ulnar were present.

Entities:  

Year:  2011        PMID: 21878097      PMCID: PMC3180257          DOI: 10.1186/1477-9560-9-13

Source DB:  PubMed          Journal:  Thromb J        ISSN: 1477-9560


  13 in total

1.  Drug points: severe ergotism associated with interaction between ritonavir and ergotamine.

Authors:  L Liaudet; T Buclin; C Jaccard; P Eckert
Journal:  BMJ       Date:  1999-03-20

2.  Recent investigations on ergot alkaloids.

Authors:  A STOLL
Journal:  Chem Rev       Date:  1950-10       Impact factor: 60.622

3.  Upper limb ischaemia due to ergotamine tartrate.

Authors:  R H Felix; J D Carroll
Journal:  Practitioner       Date:  1970-07

4.  Ergot induced peripheral vascular insufficiency, non-interventional treatment.

Authors:  T L McKiernan; K Bock; F Leya; E Grassman; B Lewis; S A Johnson; P J Scanlon
Journal:  Cathet Cardiovasc Diagn       Date:  1994-03

5.  Ergotism associated with HIV antiviral protease inhibitor therapy.

Authors:  Zachary K Baldwin; Chris C Ceraldi
Journal:  J Vasc Surg       Date:  2003-03       Impact factor: 4.268

6.  Erythromycin-associated ergotamine intoxication: arteriographic and electrophysiologic analysis of a rare cause of severe ischemia of the lower extremities and associated ischemic neuropathy.

Authors:  R Ghali; J De Léan; Y Douville; H P Noël; R Labbé
Journal:  Ann Vasc Surg       Date:  1993-05       Impact factor: 1.466

7.  Ergotamine abuse: results of ergotamine discontinuation, with special reference to the plasma concentrations.

Authors:  V Ala-Hurula; V Myllylä; E Hokkanen
Journal:  Cephalalgia       Date:  1982-12       Impact factor: 6.292

8.  Ergot intoxication: historical review and description of unusual clinical manifestations.

Authors:  G C Merhoff; J M Porter
Journal:  Ann Surg       Date:  1974-11       Impact factor: 12.969

9.  [Value of duplex ultrasound in diagnosis of ergotism of the legs].

Authors:  O Martinet; H Vuilleumier; D Fournier; A Jayet; A Genton; G Chapuis
Journal:  Swiss Surg       Date:  1995

10.  Severe iatrogenic ergotism: incidence and clinical importance.

Authors:  O Bongard; H Bounameaux
Journal:  Vasa       Date:  1991       Impact factor: 1.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.